These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37790719)

  • 1. The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.
    Sobczyk K; Holecki T; Rogalska A
    Front Public Health; 2023; 11():1207389. PubMed ID: 37790719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
    Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years.
    Mela A; Staniszewska A; Wrona W; Poniatowski ŁA; Jaroszyński J; Niewada M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):353-362. PubMed ID: 30293466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and social cost of epilepsy in Poland: 5-year analysis.
    Jędrzejczak J; Majkowska-Zwolińska B; Chudzicka-Bator A; Żerda I; Władysiuk M; Godman B
    Eur J Health Econ; 2021 Apr; 22(3):485-497. PubMed ID: 33582892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the Social Costs of Illegal Drug Use in Poland Using Standardized Methodology.
    Mielecka-Kubie ZJ
    J Ment Health Policy Econ; 2020 Sep; 23(3):139-149. PubMed ID: 33411676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social costs of loss in productivity-related absenteeism in Poland.
    Genowska A; Fryc J; Pinkas J; Jamiołkowski J; Szafraniec K; Szpak A; Bojar I
    Int J Occup Med Environ Health; 2017 Oct; 30(6):917-932. PubMed ID: 28584315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The costs of asthma in Poland in 2012].
    Jahnz-Różyk K; Kucharczyk A; Warchoł M; Radziwilska-Muc A; Władysiuk M; Plisko R
    Pol Merkur Lekarski; 2015 Aug; 39(230):91-5. PubMed ID: 26319382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect costs and public finance consequences of heart failure in Poland, 2012-2015.
    Łyszczarz B
    BMC Public Health; 2018 Sep; 18(1):1130. PubMed ID: 30231932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland.
    Kawalec PP; Malinowski KP
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
    Łyszczarz B; Nojszewska E
    BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016.
    Łyszczarz B
    BMC Public Health; 2019 May; 19(1):598. PubMed ID: 31101035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years.
    Mela A; Rdzanek E; Poniatowski ŁA; Jaroszyński J; Furtak-Niczyporuk M; Gałązka-Sobotka M; Olejniczak D; Niewada M; Staniszewska A
    Front Pharmacol; 2020; 11():1231. PubMed ID: 33013357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 pandemic and the mental health care system.
    Mavreas V; Stylianidis S
    Psychiatriki; 2022 Jun; 33(2):101-104. PubMed ID: 35593479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation.
    Russo S; Mariani TT; Migliorini R; Marcellusi A; Mennini FS
    Reumatismo; 2015 Sep; 67(2):45-56. PubMed ID: 26492962
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.